Novak Djokovic holds 80% of Danish biotech growing Covid-19 remedy: CEO
Tennis champion Novak Djokovic has an 80% stake of Danish biotech company QuantBioRes, which is aiming to increase a clinical remedy to counter COVID-19, the corporate’s leader government instructed Reuters on Wednesday.
CEO Ivan Loncarevic, who described himself as an entrepreneur, mentioned the funding used to be made in June 2020 however declined to mention how a lot it used to be.
QuantBioRes has round 11 researchers running in Denmark, Australia and Slovenia, consistent with Loncarevic, who wired they had been running on a remedy, now not a vaccine.
The corporate is growing a peptide, which inhibits the coronavirus from infecting the human cellular, expects to release medical trials in Britain this summer time, he added.
A spokesperson for Djokovic didn’t instantly reply to a request for remark.
The tennis primary has stoked international debate in regards to the rights of people that decide to not get vaccinated after he used to be deported from Australia on Sunday night time, ruling him out of the Australian Open.
